AVAH Aveanna Healthcare Holdings, Inc.

Overview and Growth

Fiscal 2025 results for Aveanna Healthcare Holdings, Inc. combined $2.43B of revenue with net income of $225.03M and an operating cash inflow of $125.86M. The $2.43B revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. The top line expanded 20.2% from $2.02B in fiscal 2024, increasing the company’s operating scale. On a per-share basis, diluted EPS was $1.05, which connects the reported earnings outcome with the company’s diluted share count. At period end, total assets were $2.01B, framing the scale of the company’s operating and financing commitments. The revenue-to-assets relationship was 1.21x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

The first profit layer was $810.48M of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross margin was 33.3%, so that share of each revenue unit remained after the cost of revenue reported for the period. Operating income was $256.46M, the earnings remaining from reported operations after the company’s recognized operating cost structure. The operating result equaled 10.5% of revenue, placing the absolute operating-income figure in the context of the company’s sales base. Net income came to $225.03M, completing the progression from revenue through gross and operating profitability to the final reported result. Net margin was 9.2%, meaning that this portion of revenue remained as net income after all recognized expenses. Pretax income was $106.95M, isolating the reported earnings outcome before the income-tax provision recognized for the fiscal year. Measured against revenue, pretax income equaled 4.4%, adding a pre-tax profitability layer between revenue and net income. An income-tax benefit of $118.09M improved the final result relative to pretax income or loss. The tax benefit equaled 110.4% of positive pretax income, lifting the after-tax result. Net income equaled 115.3% of period-end equity, showing the earnings generated on shareholders’ book capital. The net-income-to-assets relationship measured 11.2%, showing earnings relative to the full balance sheet. Net income of $225.03M replaced the $10.93M loss reported in fiscal 2024.

Liquidity and Capital Structure

At period end, the $2.01B asset base was financed through $1.82B of liabilities and $195.19M of equity. Current assets were $560.23M against $424.46M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. Current assets covered current liabilities by 1.32x, leaving a positive buffer for near-term obligations. Reported cash and equivalents were $193.26M, separating immediately recognizable cash resources from the rest of the current-asset base. The cash balance equaled 45.5% of current liabilities, showing how much near-term coverage came from cash alone. The company carried $1.30B of total debt at period end, which frames its leverage and debt-service burden. The debt-to-equity relationship was 6.66x, showing how much debt the company carried for each unit of book equity. Relative to total assets, debt measured 64.6%, showing how much of the asset base was matched by borrowing. Book equity represented 9.7% of total assets, quantifying the balance-sheet share supported by shareholder capital. The liabilities-to-assets relationship was 90.3%, placing reported obligations against the full positive asset balance. The cash-to-assets relationship was 9.6%, comparing reported cash and equivalents with the full positive asset balance. Compared with $1.66B in fiscal 2024, the current asset base moved 21.0% and finished higher. The reported cash balance changed 129.3% from $84.29M in fiscal 2024, ending higher year over year.

Cash Flow and Earnings Quality

Cash flow from operations was $125.86M, a reported cash inflow that can be compared directly with net income and capital spending. The operating-cash-flow-to-net-income relationship was 0.56x, comparing cash generated by operations with the bottom-line earnings result.

Based on the annual report for the fiscal year ending Jan 3, 2026. Analysis generated Oct 21, 2026.